ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1389

Association Of Dry Eye Severity With Salivary Flow In Patients With Primary Sjögren’s Syndrome

Janett C. Riega-Torres1, Karina Palomo-Arnaud2, Jose Martinez-Delgado3, Fernando Morales-Wong3, Jesus Mohamed-Hamsho3, Valeria Mata-Riega2, Irma Cantu-Zapata2, Luis Medina-Gomez2, Miguel Betancourt-De la Torre2, Aritze Chong-Amezcua2, Dionicio A. Galarza-Delgado4 and Karim Mohamed-Noriega3, 1Rheumatology Service, Hospital Universitario “Dr. Jose Eleuterio Gonzalez”, Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo Leon, Mexico, 2Hospital Universitario "Dr. José Eleuterio González", Rheumatology, Monterrey, Nuevo León, Monterrey, Nuevo Leon, Mexico, 3Hospital Universitario "Dr. José Eleuterio González", Ofthalmology, Monterrey, Nuevo León, Monterrey, Nuevo Leon, Mexico, 4Rheumatology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico

Meeting: ACR Convergence 2025

Keywords: Eye Disorders, Sjögren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1376–1404) Sjögren’s Disease – Basic & Clinical Science Poster II: Clinical Manifestations and Health Outcomes

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Sjögren’s Syndrome (SS) is a multisystemic autoimmune disease that causes hypofunction of salivary and lacrimal glands, manifesting in xerostomia and xerophthalmia among other systemic manifestations. Unstimulated whole salivary flow rate (UWSF) is a test used to quantify saliva production, a decrease in USWF rate impacts the quality of life in patients with SS. Similarly, dry eye tests are useful tools in everyday clinical practice to identify inflammatory damage to the ocular surface. An abnormal UWSF, along with positive serology, a reduced Schirmer’s test, and a positive minor salivary gland biopsy is included in the 2016 ACR/EULAR SS classification criteria. However, the association between UWSF and dry eye tests is poorly known. We aimed to explore if there is an association between UWSF and dry eye severity.

Methods: A cohort of rheumatic patients with dry eye disease (DED) (2015-2024) was analyzed. Patients aged 18-years or older, with DED symptoms and primary SS diagnosis (according to ACR-EULAR 2016 criteria) were included. Patients were divided into two groups according to UWSF in 5 minutes (group 1: UWSF ≤0.5 ml/5min, group 2: UWSF >0.5 ml/5min). MSG biopsy, tear film osmolarity (OSM), matrix metalloproteinase 9 (MMP-9), Ocular Surface Disease Index (OSDI), Tear break-up time (TBUT), SICCA Ocular Surface Staining (SICCA OSS), and Schirmer tear test with and without anesthesia (STT) were evaluated. Only the worst eye was included, which was selected as the eye with the higher SICCA OSS score. Associations and results were presented using (frequencies [%], mean ± SD, median [IQR]), and we used Chi2, Mann-Whitney U, or Student’s tests as appropriate. Institutional ethics committee approval was received; all participants provided written informed consent.

Results: Eighty-nine patients with primary SS were included, the mean age was 52.6 ± 12.8 years, and 97.7% (87/89) were women. Forty-three (48.3%) patients had a UWSF ≤0.5 ml/5 min, and 46 (51.7%) patients had a UWSF >0.5 ml/5 min. We observed a higher proportion of patients with positive MMP-9 in the UWSF ≤0.5 ml/5 min group (15/43,34.9%) than those with a UWSF >0.5 ml/5 min (7/46,15.2%; p=0.041). Patients with UWSF ≤0.5 ml/5 min also showed higher OSDI scores (48.85 ± 27.83) than patients with UWSF >0.5 ml/5 min (34.76 ± 21.58; p=0.010). There was no difference in SICCA OSS scores, Schirmer’s tear test with or without anesthesia, tear film osmolarity, and tear break-up time.

Conclusion: Patients with low salivary flow had greater ocular surface damage and more dry eye disease symptoms.

Supporting image 1Table 1. Dry eye severity according to unstimulated whole salivary flow rate (UWSF) among patients with Sjögren’s Syndrome.


Disclosures: J. Riega-Torres: None; K. Palomo-Arnaud: None; J. Martinez-Delgado: None; F. Morales-Wong: None; J. Mohamed-Hamsho: None; V. Mata-Riega: None; I. Cantu-Zapata: None; L. Medina-Gomez: None; M. Betancourt-De la Torre: None; A. Chong-Amezcua: None; D. Galarza-Delgado: None; K. Mohamed-Noriega: None.

To cite this abstract in AMA style:

Riega-Torres J, Palomo-Arnaud K, Martinez-Delgado J, Morales-Wong F, Mohamed-Hamsho J, Mata-Riega V, Cantu-Zapata I, Medina-Gomez L, Betancourt-De la Torre M, Chong-Amezcua A, Galarza-Delgado D, Mohamed-Noriega K. Association Of Dry Eye Severity With Salivary Flow In Patients With Primary Sjögren’s Syndrome [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/association-of-dry-eye-severity-with-salivary-flow-in-patients-with-primary-sjogrens-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-dry-eye-severity-with-salivary-flow-in-patients-with-primary-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology